Tweet
AAF rejecting JAAA's public warning for Fraser?
Friday, 10 September 2010 07:25
Shelly-Ann FraserFrom the news now being surfaced, the International Association of Athletics Federations (IAAF), has apparently, flatly rejected an initial recommendation from the Jamaica Amateur Athletic Association (JAAA), that star sprinter Shelly-Ann Fraser, gets away with a minimum form of penalty for a drug violation.
A minimum form of penalty usually comes in the form of a public warning.
Fraser, who had previously never been involved in any form of drug allegations in her athletic career, tested positive for what proved to be a painkiller she had used to ease extreme pain she was experiencing from recent dental work and a non-performance enhancer.
In other words, it was apparent to all, that she didn't ingest the painkiller oxycodone, so that she could gain an advantage on her competition.
This is contrary to the JAAA's release issued on Wednesday, which stated: "The (JAAA) Tribunal was of the view, that there were circumstances in the athlete's case which may be 'exceptional and special' and therefore referred the case to the IAAF's Doping Review Board for determination."
The release further stated that, "The Doping Review Board has now replied that they have agreed with the Tribunal, that special circumstances are met for a reduction of sanction in the athlete's case from two (2) years."
Now, according to the Jamaica Observer, it appears that the governing body for world athletics will go with a recommendation for a suspension of no longer than six months.
Fraser, a member of the MVP club, which includes former 100 metres world record-holder Asafa Powell, sprinters Michael Frater and Nesta Carter, and female competitors, hurdlers Brigitte Foster Hylton, Melaine Walker, Kaliese Spencer and sprinter Sherone Simpson, tested positive for the banned substance Oxycodone at a meet in Shanghai, China on May 23.
Friday, 10 September 2010 07:25
Shelly-Ann FraserFrom the news now being surfaced, the International Association of Athletics Federations (IAAF), has apparently, flatly rejected an initial recommendation from the Jamaica Amateur Athletic Association (JAAA), that star sprinter Shelly-Ann Fraser, gets away with a minimum form of penalty for a drug violation.
A minimum form of penalty usually comes in the form of a public warning.
Fraser, who had previously never been involved in any form of drug allegations in her athletic career, tested positive for what proved to be a painkiller she had used to ease extreme pain she was experiencing from recent dental work and a non-performance enhancer.
In other words, it was apparent to all, that she didn't ingest the painkiller oxycodone, so that she could gain an advantage on her competition.
This is contrary to the JAAA's release issued on Wednesday, which stated: "The (JAAA) Tribunal was of the view, that there were circumstances in the athlete's case which may be 'exceptional and special' and therefore referred the case to the IAAF's Doping Review Board for determination."
The release further stated that, "The Doping Review Board has now replied that they have agreed with the Tribunal, that special circumstances are met for a reduction of sanction in the athlete's case from two (2) years."
Now, according to the Jamaica Observer, it appears that the governing body for world athletics will go with a recommendation for a suspension of no longer than six months.
Fraser, a member of the MVP club, which includes former 100 metres world record-holder Asafa Powell, sprinters Michael Frater and Nesta Carter, and female competitors, hurdlers Brigitte Foster Hylton, Melaine Walker, Kaliese Spencer and sprinter Sherone Simpson, tested positive for the banned substance Oxycodone at a meet in Shanghai, China on May 23.
Comment